论文信息 - Persistent Superior Vena Caval Syndrome Due to Totally Implantable Venous Access Systems

Persistent Superior Vena Caval Syndrome Due to Totally Implantable Venous Access Systems

Totally implanted venous access systems are widely used in cystic fibrosis and have a low incidence of complications. Whilst local venous thromboses are described with these devices, we have found no previous reports of permanent superior vena caval occlusion.

M. Walshaw | M. Ledson | P. Stockton

[1] J. Pepper,et al. Experience of totally implantable venous access devices (TIV ADs) in adults with cystic fibrosis over a 13-year period. , 2000, Respiratory medicine.

[2] S. Sawyer,et al. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications , 1998, Thorax.

[3] C. Haworth,et al. Recurrent venous thrombosis in a patient with cystic fibrosis , 1995, Pediatric pulmonology.

[4] M. Hodson,et al. Long term venous access using a totally implantable drug delivery system in patients with cystic fibrosis and bronchiectasis. , 1989, Respiratory medicine.

[5] G. Saeter,et al. Fifty‐five patient years' experience with a totally implanted system for intravenous chemotherapy , 1986, Cancer.

[6] E. Thomas,et al. A modified right atrial catheter for access to the venous system in marrow transplant recipients. , 1979, Surgery, gynecology & obstetrics.